Inoviq Ltd (OTCPK:BDLSF)
$ 0.12 0 (0%) Market Cap: 34.00 Mil Enterprise Value: 31.69 Mil PE Ratio: 0 PB Ratio: 2.86 GF Score: 27/100

INOVIQ Ltd at ASX Small and Mid-Cap Conference Transcript

Sep 20, 2023 / NTS GMT
Release Date Price: $0.12
Unidentified Participant

Speaking with Leearne Hinch this morning from INOVIQ. Leearne, good to see.

Leearne Hinch
INOVIQ Ltd - CEO

Good to see you, too.

Questions & Answers

Unidentified Participant

Well, Leearne, just firstly give us a brief bit of background here to INOVIQ the business.

Leearne Hinch
INOVIQ Ltd - CEO

INOVIQ is a biotechnology company developing next-generation precision diagnostics and exosome solutions for cancer. We've got a pipeline of products in development, including our breast cancer and ovarian cancer monitoring and screening tests. We've also got exosome solutions for isolating exosomes that can then be used for developing new diagnostics. And we've got our own ovarian cancer diagnostic in development for screening ovarian cancer.

So we're pretty busy company, a lot of products in the pipeline, and some very exciting upcoming data readouts. Our SubB2M test, we recently announced clinical validation data for our leading test or our most advanced

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot